Acrobot Pursues Orthopedic Partners In Multiple Markets
This article was originally published in The Gray Sheet
Acrobot is seeking a partner to help market its line of "intelligent surgical tools" in the U.S. orthopedic implant surgery market beginning in 2009
You may also be interested in...
Wright Medical Group appoints Kevin Cordell president, U.S. extremities; wound therapy patch developer Reapplix names CEO; Sotera Wireless taps senior VP, sales and marketing.
Corin Group will distribute Acrobot's Acrobot Navigation electromagnetic navigation system for hip resurfacing surgeries in the UK, Germany and Australia. Under the agreement announced May 27, Corin will buy the systems from Acrobot and market them alongside its Cormet hip resurfacing system.The agreement is London-based Acrobot's first commercial route-to-market agreement. Corin and Acrobot have been cooperating to adapt Acrobot's system for hip resurfacing since 2004, and at the end of 2007 Corin owned about 10% of the company. Acrobot's other partners include Biomet, Stanmore Implants and the Imperial College London
Pipeline is concentrated around Phase II, but sponsors have a few chances to see how FDA handles its ‘foundational constructs’ for psychedelic drugs, led by Lykos’ pending NDA for PTSD and Compass Pathways’ Phase III synthetic psilocybin COMP360 for treatment-resistant depression.